174 related articles for article (PubMed ID: 19040614)
21. Transcriptional analysis of THP-1 cells infected with Leishmania infantum indicates no activation of the inflammasome platform.
Gatto M; Borim PA; Wolf IR; Fukuta da Cruz T; Ferreira Mota GA; Marques Braz AM; Casella Amorim B; Targino Valente G; de Assis Golim M; Venturini J; Araújo Junior JP; Pontillo A; Sartori A
PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007949. PubMed ID: 31961876
[TBL] [Abstract][Full Text] [Related]
22. Skin-derived macrophages from Leishmania major-susceptible mice exhibit interleukin-12- and interferon-gamma-independent nitric oxide production and parasite killing after treatment with immunostimulatory DNA.
von Stebut E; Belkaid Y; Nguyen B; Wilson M; Sacks DL; Udey MC
J Invest Dermatol; 2002 Sep; 119(3):621-8. PubMed ID: 12230504
[TBL] [Abstract][Full Text] [Related]
23. The role of IL-10 in promoting disease progression in leishmaniasis.
Kane MM; Mosser DM
J Immunol; 2001 Jan; 166(2):1141-7. PubMed ID: 11145695
[TBL] [Abstract][Full Text] [Related]
24. The human cytokine response to Leishmania major early after exposure to the parasite in vitro.
Rogers KA; Titus RG
J Parasitol; 2004 Jun; 90(3):557-63. PubMed ID: 15270099
[TBL] [Abstract][Full Text] [Related]
25. The levels and patterns of cytokines produced by CD4 T lymphocytes of BALB/c mice infected with Leishmania major by inoculation into the ear dermis depend on the infectiousness and size of the inoculum.
Lang T; Courret N; Colle JH; Milon G; Antoine JC
Infect Immun; 2003 May; 71(5):2674-83. PubMed ID: 12704142
[TBL] [Abstract][Full Text] [Related]
26. Leishmania tropica: suggestive evidences for the effect of infectious dose on pathogenicity and immunogenicity in an experimental model.
Rostamian M; Jafari D; Abolghazi M; Farahani H; Niknam HM
Parasitol Res; 2018 Sep; 117(9):2949-2956. PubMed ID: 29978420
[TBL] [Abstract][Full Text] [Related]
27. Infection of human monocytes by Leishmania results in a defective oxidative burst.
Passwell JH; Shor R; Smolen J; Jaffe CL
Int J Exp Pathol; 1994 Aug; 75(4):277-84. PubMed ID: 7947230
[TBL] [Abstract][Full Text] [Related]
28. Cyclobenzaprine Raises ROS Levels in Leishmania infantum and Reduces Parasite Burden in Infected Mice.
Cunha-Júnior EF; Andrade-Neto VV; Lima ML; da Costa-Silva TA; Galisteo Junior AJ; Abengózar MA; Barbas C; Rivas L; Almeida-Amaral EE; Tempone AG; Torres-Santos EC
PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005281. PubMed ID: 28045892
[TBL] [Abstract][Full Text] [Related]
29. Monocyte chemotactic protein-1 stimulates the killing of leishmania major by human monocytes, acts synergistically with IFN-gamma and is antagonized by IL-4.
Ritter U; Moll H
Eur J Immunol; 2000 Nov; 30(11):3111-20. PubMed ID: 11093125
[TBL] [Abstract][Full Text] [Related]
30. Experimental pathogenicity of viscerotropic and dermotropic isolates of Leishmania infantum from immunocompromised and immunocompetent patients in a murine model.
Sulahian A; Garin YJ; Pratlong F; Dedet JP; Derouin F
FEMS Immunol Med Microbiol; 1997 Mar; 17(3):131-8. PubMed ID: 9093833
[TBL] [Abstract][Full Text] [Related]
31. Leishmania donovani Metacyclic Promastigotes Impair Phagosome Properties in Inflammatory Monocytes.
Matte C; Arango Duque G; Descoteaux A
Infect Immun; 2021 Jun; 89(7):e0000921. PubMed ID: 33875473
[TBL] [Abstract][Full Text] [Related]
32. Leishmania major: differential resistance to infection in C57BL/6 (high interferon-alpha/beta) and congenic B6.C-H-28c (low interferon-alpha/beta) mice.
Shankar AH; Morin P; Titus RG
Exp Parasitol; 1996 Nov; 84(2):136-43. PubMed ID: 8932763
[TBL] [Abstract][Full Text] [Related]
33. Leishmania infantum induces high phagocytic capacity and intracellular nitric oxide production by human proinflammatory monocyte.
Ribeiro CV; Rocha BFB; Oliveira E; Teixeira-Carvalho A; Martins-Filho OA; Murta SMF; Peruhype-Magalhães V
Mem Inst Oswaldo Cruz; 2020; 115():e190408. PubMed ID: 32321156
[TBL] [Abstract][Full Text] [Related]
34. CD40 signaling induces reciprocal outcomes in Leishmania-infected macrophages; roles of host genotype and cytokine milieu.
Nunes MP; Cysne-Finkelstein L; Monteiro BC; de Souza DM; Gomes NA; DosReis GA
Microbes Infect; 2005 Jan; 7(1):78-85. PubMed ID: 15716074
[TBL] [Abstract][Full Text] [Related]
35. Vaccination with the Leishmania infantum ribosomal proteins induces protection in BALB/c mice against Leishmania chagasi and Leishmania amazonensis challenge.
Chávez-Fumagalli MA; Costa MA; Oliveira DM; Ramírez L; Costa LE; Duarte MC; Martins VT; Oliveira JS; Olortegi CC; Bonay P; Alonso C; Tavares CA; Soto M; Coelho EA
Microbes Infect; 2010 Nov; 12(12-13):967-77. PubMed ID: 20601076
[TBL] [Abstract][Full Text] [Related]
36. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan.
Halliday A; Bates PA; Chance ML; Taylor MJ
Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391
[TBL] [Abstract][Full Text] [Related]
37. F₁ cross-breed between susceptible BALB/c and resistant Swiss mice infected with Leishmania major exhibit an intermediate phenotype for lesion sizes and type 1 cytokines but show low level of total IgG antibodies.
Kiige SG; Mutiso JM; Laban LT; Khayeka-Wandabwa C; Anjili CO; Ingonga J; Gicheru MM
Scand J Immunol; 2014 May; 79(5):283-91. PubMed ID: 24498914
[TBL] [Abstract][Full Text] [Related]
38. Leishmania infantum: soluble proteins released by the parasite exert differential effects on host immune response.
Rosa R; Rodrigues OR; Marques C; Santos-Gomes GM
Exp Parasitol; 2005 Feb; 109(2):106-14. PubMed ID: 15687017
[TBL] [Abstract][Full Text] [Related]
39. Intradermal inoculations of low doses of Leishmania major and Leishmania amazonensis metacyclic promastigotes induce different immunoparasitic processes and status of protection in BALB/c mice.
Courret N; Lang T; Milon G; Antoine JC
Int J Parasitol; 2003 Oct; 33(12):1373-83. PubMed ID: 14527520
[TBL] [Abstract][Full Text] [Related]
40. Heterogeneity of wild Leishmania major isolates in experimental murine pathogenicity and specific immune response.
Kébaïer C; Louzir H; Chenik M; Ben Salah A; Dellagi K
Infect Immun; 2001 Aug; 69(8):4906-15. PubMed ID: 11447167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
